I wanted to explain a move I made yesterday which looks pretty stupid right now. I sold out of athenaHealth (ATHN) and replaced it with Alexion Pharma (ALXN). Today athenaHealth pushed through a previous level of resistance too a new all time high of $63. That's a 6.5% move in one day! I actually own athenaHealth personally so this move seems strange. Alexion only makes one drug called Soliris to treat paroxysmal nocturnal hemoglobinuria, or PNH. The rub is that they expect the FDA to approve Soliris to treat Hemolytic Uremic Syndrome, or aHUS, as early as the fourth quarter. If approved, Alexion is ready to launch Soliris for aHUS the same quarter. This could double their sales. When BioTech works, you can get some of the juiciest gains in the business. It's high risk/ high reward and I wanted to put a more speculative stock in the portfolio. While I lost some gains on athenaHealth (ATHN) in the short term, I think we can hit a homerun with Alexion.
No comments:
Post a Comment